Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0701 Gastric Cancer Prevention 6/16/2009 6/30/2010 100% Published
    Closed S0910 Cytarabine/Clofarabine +/- Epratuzumab for Relapsed/Refractory B-cell ALL 8/15/2010 7/1/2012 100% Published
    Closed S0806 Phase I/II DLBCL Vorinostat with R-CHOP 11/15/2010 10/1/2013 100% Published
    Closed S0925 New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II 12/15/2010 12/1/2012 100% Published
    Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
    Closed S1007 ADJUVANT: Phase III Randomized Endocrine Therapy +/- Chemo according to RS 1/15/2011 100%
    Closed S0931 Adjuvant Renal Cell, Everolimus vs Placebo, Ph III 4/1/2011 9/15/2016 100%
    Closed S1011 Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III 8/1/2011 4/15/2017 100%
    Closed S1001 Phase II Early Stage DLBCL 7/18/2011 6/1/2016 100%
    Closed S0927 Ph III Omega-3 fatty acid/placebo Breast Cancer 2/1/2012 2/1/2013 100% Published
    Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
    Closed S1119 Water Contamination Study 12/2/2011 8/5/2013 100% Published
    Closed S1008 Physical activity & dietary change weight loss in breast & colorectal survivors Ph II 3/1/2012 7/1/2014 100%
    Closed S1117 Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML 3/1/2012 11/14/2014 100% Published
    Closed S1105 Text Messaging Study 3/27/2012 9/15/2013 100%
    Closed S1115 Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo 8/15/2012 5/15/2014 100% Published
    Closed S1211 PII Optimal Induction for HRMM 10/12/2012 100%
    Closed S1207 Ph. III Randomized, Everolimus in high risk, hormone receptor positive, HER2 negative patients. 9/3/2013 5/1/2019 100%
    Closed S1216 Metastatic Prostate Cancer, Phase III ADT+TAK-700 vs. ADT+Bicalutamide 3/1/2013 7/15/2017 100%
    Closed S1202 Ph III Study of Duloxetine for AI-associated musculoskleteal symptoms for Early Stage BrCa 5/15/2013 10/1/2015 100% Published
    Scroll Table